WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010026262) PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/026262    International Application No.:    PCT/EP2009/061656
Publication Date: 11.03.2010 International Filing Date: 08.09.2009
IPC:
C07D 487/04 (2006.01), A61K 31/519 (2006.01), A61P 35/00 (2006.01)
Applicants: BOEHRINGER INGELHEIM INTERNATIONAL GMBH [DE/DE]; Binger Strasse 173 55216 Ingelheim Am Rhein (DE) (For All Designated States Except US).
MANTOULIDIS, Andreas [DE/DE]; (DE) (For US Only).
DAHMANN, Georg [DE/DE]; (DE) (For US Only).
ETTMAYER, Peter [AT/DE]; (DE) (For US Only).
KLEIN, Christian [DE/DE]; (DE) (For US Only).
STEURER, Steffen [DE/DE]; (DE) (For US Only).
WAIZENEGGER, Irene [DE/DE]; (DE) (For US Only).
ZAHN, Stephan Karl [DE/DE]; (DE) (For US Only)
Inventors: MANTOULIDIS, Andreas; (DE).
DAHMANN, Georg; (DE).
ETTMAYER, Peter; (DE).
KLEIN, Christian; (DE).
STEURER, Steffen; (DE).
WAIZENEGGER, Irene; (DE).
ZAHN, Stephan Karl; (DE)
Agent: HAMMANN, Heinz, et al.; (DE)
Priority Data:
08163897.5 08.09.2008 EP
Title (EN) PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS
(FR) PYRIDO-[5,4-D]-PYRIMIDINES EN TANT QU’INHIBITEURS DE PROLIFÉRATION CELLULAIRE
Abstract: front page image
(EN)The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, X1, X2, X3, L1 and L2 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof in such a treatment.
(FR)La présente invention concerne des composés de formule générale (1) dans laquelle les groupes R1 à R4, X1, X2, X3, L1 et L2 sont définis comme décrit dans la revendication 1, qui sont adaptés pour le traitement de maladies caractérisées par une prolifération cellulaire anormale, et l’utilisation de ceux-ci dans un tel traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)